Baxter’s Strategic Pivot: A Deep Dive into Its Financial Restructuring Plan
09.01.2026 - 18:11:05
Medical device giant Baxter International is implementing a comprehensive financial and operational strategy to counter persistent margin compression and manufacturing challenges. The company’s recent moves, including a drastic dividend cut and a new hospital partnership, have drawn mixed reactions from Wall Street, setting the stage for a critical investor update next week.
Market analysts presented contrasting perspectives on Baxter’s outlook this week. Barclays reaffirmed its Overweight rating on the stock but made a significant downward revision to its price target, lowering it from $36 to $30. Conversely, Goldman Sachs maintained a Neutral stance while nudging its target price slightly higher to $23. This split underscores the uncertainty surrounding the company’s Read more...
